openPR Logo
Press release

Adoptive Cellular Immunotherapy Market Rising at a High CAGR by Forecast Period 2020-2025 with Top Vendors Like Amgen, Autolus Therapeutics, Beijing Immunochina, Bellicum, Bristol-Myers Squibb

10-30-2020 05:02 PM CET | Health & Medicine

Press release from: Business Industry Reports

Adoptive Cellular Immunotherapy

Adoptive Cellular Immunotherapy

The growing demand for Adoptive Cellular Immunotherapy has provided a major boost to the Global Adoptive Cellular Immunotherapy Market as more people are shifting their preferences to this growing sector. The market is expected to keep rising at a high CAGR and reach values of high millions by the end of the forecast period of 2020 up to 2025.

Global Adoptive Cellular Immunotherapy Market overview:

Adoptive cell therapy, also known as cellular immunotherapy, is a form of treatment that uses the cells of our immune system to eliminate cancer. Some of these approaches involve directly isolating our own immune cells and simply expanding their numbers, whereas others involve genetically engineering our immune cells (via gene therapy) to enhance their cancer-fighting capabilities. The Global Adoptive Cellular Immunotherapy Market is segmented on the basis of Product Type, Application, End Use Industry and Region. This report also covers all the regions and countries of the world, which shows a regional development status, including market size.

Our immune system is capable of recognizing and eliminating cells that have become infected or damaged as well as those that have become cancerous. In the case of cancer, immune cells known as killer T cells are particularly powerful against cancer, due to their ability to bind to markers known as antigens on the surface of cancer cells.

Available Exclusive Sample Copy of this Report @ https://www.businessindustryreports.com/sample-request/280063 .

On the Basis of Product Type segment, the Adoptive Cellular Immunotherapy Market is sub segmented into TIL, LAK, CAR-T, TCR-T, CIK, NK, DC and Other. Based on End Use Industry segment, the Adoptive Cellular Immunotherapy Market is segmented as Hospital, Cancer Hospital, Centers for Disease Control and Prevention, Rehabilitation Center and Other.

There are several manufacturers of Adoptive Cellular Immunotherapy in Europe and North America. In North America, the demand for Adoptive Cellular Immunotherapy is primarily driven by the Healthcare sector. Among the countries in Asia Pacific, the demand was substantially high in developing countries such as China and India.

Purchase this report online with 90 Pages, List of Tables & Figures and in-depth Table of Contents on “Adoptive Cellular Immunotherapy Market Report 2020” @ https://www.businessindustryreports.com/buy-now/280063/single .

Top Industry News:

Amgen Announces Participation Of Systemic Lupus Erythematosus (SLE) Adaptive Clinical Trial In The FDA Complex Innovative Trial Designs (CID) Pilot Program on 27 October, 2020 -- Amgen today announced that it has completed trial design discussions through two Complex Innovative Trial Designs (CID) Pilot Program meetings with the U.S. Food and Drug Administration (FDA) for its planned Phase 2 efficacy and safety trial for efavaleukin alfa (formerly known as AMG 592), an investigational candidate for Systemic Lupus Erythematosus (SLE) treatment. The CID Pilot Program aims to modernize drug development, improve efficiency, and promote innovation. The efavaleukin alfa participation in the CID Pilot Program is based on an innovative adaptive clinical trial design developed to foster the acceleration of a potential therapeutic option that could benefit patients living with SLE.

"Systemic Lupus Erythematosus is an area with significant need for new therapies for those living with the condition, but one that has been challenging to address given the complexity of this autoimmune disease," said Rob Lenz, M.D., Ph.D., senior vice president, Global Development at Amgen. "Our partnership with the FDA on the CID Pilot Program should drive the development of a new treatment for lupus to address unmet need for patients."

"Amgen welcomes the opportunity to partner with the FDA through participation in the CID Pilot Program, which intends to advocate innovative clinical trial designs, as well as provide the FDA an opportunity to communicate these advances publicly," said Steven Galson, M.D., senior vice president, Global Regulatory Affairs and Strategy at Amgen. "We appreciate the FDA's efforts, significant contributions and feedback provided throughout the Pilot process."

The CID Pilot Program fulfills a performance goal agreed to under the Prescription Drug User Fee Act (PDUFA) VI, aiming to facilitate and advance the use of novel clinical trial designs that support the development and regulatory review of new therapeutics. Designs under the CID umbrella include, but are not limited to, complex adaptive, Bayesian, and other novel clinical trial designs which often require simulations to determine the statistical properties of the trial. The FDA considers several eligibility factors when selecting qualifying programs, including the level of innovation of the trial design, and the therapeutic need.

Grab Your Report at an Impressive Discount @ https://www.businessindustryreports.com/check-discount/280063 .

Major Key Players:

Some of the Adoptive Cellular Immunotherapy Market manufacturers involved in the market are Amgen Inc, Autolus Therapeutics Plc, Beijing Immunochina Medical Science & Technology Co Ltd, Bellicum Pharmaceuticals Inc, Bristol-Myers Squibb Co, bluebird bio Inc, CARsgen Therapeutics Ltd, Celgene Corp, Cell Medica Ltd, Cellular Biomedicine Group Inc, Celularity Inc, Celyad SA, Daiichi Sankyo Co Ltd, Fosun Pharmaceutical AG, Gilead Sciences Inc, Guangzhou Anjie Biomedical Technology Co Ltd, Hangzhou Converd Co Ltd, Hebei Senlang Biotechnology Inc Ltd, HRAIN Biotechnology Co Ltd, Juno Therapeutics Inc, Kite Pharma Inc, Nanjing Legend Biotech Co Ltd, NantKwest Inc, Nkarta Inc, Novartis AG, Ono Pharmaceutical Co Ltd, Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd, Sorrento Therapeutics Inc, Takara Bio Inc in World, effective mergers are some of the strategies adopted by the Adoptive Cellular Immunotherapy Market manufacturers. New product launches and continuous technological innovations are the Adoptive Cellular Immunotherapy Market strategies adopted by the major players.

Table of Contents:

1 Adoptive Cellular Immunotherapy Product Definition
2 Global Adoptive Cellular Immunotherapy Market Manufacturer Share and Market Overview
2.1 Global Manufacturer Adoptive Cellular Immunotherapy Shipments
2.2 Global Manufacturer Adoptive Cellular Immunotherapy Business Revenue
2.3 Global Adoptive Cellular Immunotherapy Market Overview
3 Manufacturer Adoptive Cellular Immunotherapy Business Introduction
3.1 Amgen Inc Adoptive Cellular Immunotherapy Business Introduction
3.1.1 Amgen Inc Adoptive Cellular Immunotherapy Shipments, Price, Revenue and Gross profit 2020-2025
3.1.2 Amgen Inc Adoptive Cellular Immunotherapy Business Distribution by Region
3.1.3 Amgen Inc Interview Record
3.1.4 Amgen Inc Adoptive Cellular Immunotherapy Business Profile
3.1.5 Amgen Inc Adoptive Cellular Immunotherapy Product Specification
3.2 Autolus Therapeutics Plc Adoptive Cellular Immunotherapy Business Introduction
3.2.1 Autolus Therapeutics Plc Adoptive Cellular Immunotherapy Shipments, Price, Revenue and Gross profit 2020-2025
3.2.2 Autolus Therapeutics Plc Adoptive Cellular Immunotherapy Business Distribution by Region
3.2.3 Interview Record
3.2.4 Autolus Therapeutics Plc Adoptive Cellular Immunotherapy Business Overview
3.2.5 Autolus Therapeutics Plc Adoptive Cellular Immunotherapy Product Specification
3.3 BEIJING IMMUNOCHINA MEDICAL SCIENCE & TECHNOLOGY CO LTD Adoptive Cellular Immunotherapy Business Introduction
3.3.1 BEIJING IMMUNOCHINA MEDICAL SCIENCE & TECHNOLOGY CO LTD Adoptive Cellular Immunotherapy Shipments, Price, Revenue and Gross profit 2020-2025
3.3.2 BEIJING IMMUNOCHINA MEDICAL SCIENCE & TECHNOLOGY CO LTD Adoptive Cellular Immunotherapy Business Distribution by Region
3.3.3 Interview Record
3.3.4 BEIJING IMMUNOCHINA MEDICAL SCIENCE & TECHNOLOGY CO LTD Adoptive Cellular Immunotherapy Business Overview
3.3.5 BEIJING IMMUNOCHINA MEDICAL SCIENCE & TECHNOLOGY CO LTD Adoptive Cellular Immunotherapy Product Specification
3.4 Bellicum Pharmaceuticals Inc Adoptive Cellular Immunotherapy Business Introduction
3.5 Bristol-Myers Squibb Co Adoptive Cellular Immunotherapy Business Introduction
3.6 Bluebird bio Inc Adoptive Cellular Immunotherapy Business Introduction

About us

BusinessindustryReports.com is digital database of comprehensive market reports for global industries. As a market research company, we take pride in equipping our clients with insights and data that holds the power to truly make a difference to their business. Our mission is singular and well-defined – we want to help our clients envisage their business environment so that they are able to make informed, strategic and therefore successful decisions for themselves.

Media Contact

Business Industry Reports

Pune – India

sales@businessindustryreports.com

+19376349940

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Adoptive Cellular Immunotherapy Market Rising at a High CAGR by Forecast Period 2020-2025 with Top Vendors Like Amgen, Autolus Therapeutics, Beijing Immunochina, Bellicum, Bristol-Myers Squibb here

News-ID: 2177470 • Views: 492

More Releases from Business Industry Reports

Loperamide HCl Market Emerging by Trends and Shares During the Forecast Period 2 …
The report on Global Loperamide HCl Market 2020 includes a study of annual and financial reports of top players, Market Share and Market Size. This research report offers in-depth study of Key Players, Product and Regional Analysis over the forecast period (2020-2025). Global Loperamide HCl Market overview: Loperamide, sold under the brand name Imodium, among others, is a medication used to decrease the frequency of diarrhea. It is often used for this
Growth Opportunities in the Epidermal Growth Factor (EGF) Market and Leading Key …
A market study ”Global Epidermal Growth Factor (EGF) Market” examines the performance of the Global Epidermal Growth Factor (EGF) Market 2020. It encloses an in-depth Research of the Epidermal Growth Factor (EGF) Market state and the competitive landscape globally. This report analyzes the potential of Epidermal Growth Factor (EGF) Market in the present and the future prospects from various angles in detail. Overview of Global Epidermal Growth Factor (EGF) Market: The Global
Emergency Ambulance Market Value to Expand $$3.13 Billion by 2025 | Internationa …
All information provided in the report is derived from trusted industrial sources. Global Emergency Ambulance Market research reports finds market figures between 2020 and 2025. The market will exhibit remarkable CAGRs in the aforementioned period. Global Emergency Ambulance Market Overview: The Global Emergency Ambulance Market has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Emergency Ambulance market size to maintain the average annual growth
Present Scenario and Growth Prospects of Benzalkonium Chloride Market Over The P …
The exclusive research report on the Global Benzalkonium Chloride Market 2020 examines the market in detail along with focusing on significant market dynamics for the key players operating in the market. Global Benzalkonium Chloride Industry research report offers granulated yet in-depth analysis of revenue share, market segments, revenue estimates and various regions across the globe. Overview of Global Benzalkonium Chloride Market: The Global Benzalkonium Chloride Market has also suffered a certain impact,

All 5 Releases


More Releases for Cell

Single Cell Analysis Market
Single Cell Analysis Market Size Worth $ 4,752.19 Million By 2026 | CAGR: 18.4% The global Single Cell Analysis market size is expected to reach USD 4,752.19 million by 2026 according to a new study by WhipSmart MI Research. The report “Single Cell Analysis Market By Product (Consumables and Instruments), Cell Type (Human, Microbial and Animal), Technique (Flow Cytometers, Next-Generation Sequencing, Polymerase Chain Reaction, Microscopy, Mass Spectrometry and Other Techniques), Application
Fuel Cell Vehicle Market
The report aims to provide an overview of the global Fuel Cell Vehicle Market with detailed market segmentation by technology, vehicle type, and geography. The global fuel cell vehicle market is expected to witness high growth during the forecast period. The fuel cell vehicle market report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market. Get Sample Copy of
Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect …
Researchmoz added Most up-to-date research on "Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect Cell and Others" to its huge collection of research reports. This report researches the worldwide GMP Cell Banking market size (value, capacity, production and consumption) in key regions like North America, Europe, Asia Pacific (China, Japan) and other regions. This study categorizes the global GMP Cell Banking breakdown data by manufacturers, region, type
Cell Culture Market Size, Cell Culture Market Share, Cell Culture Market Trends …
According to a new research published by Polaris Market Research the global cell culture market is anticipated to reach more than USD 49 billion by 2026. Cell culture is a rapidly emerging as an implement for analyzing and treating various disease such as Alzheimer’s and cancer. Request for Sample of This Research Report @ https://bit.ly/2D7pZ5u Top Key Players: - Becton, Dickinson and Company Biospherix EMD Millipore Eppendorf AG Merck KGaA Sartorius AG VWR International Cell culture is a rapidly emerging
Cell Therapy Market Cell Therapy Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents Introduction to Cell Therapy Necessity for Cell Therapy Treatment 2.1 Emergence of Stem Cell Research 2.2 Benefits of Using the Stem Cell for Research and Treatment Application of Stem Cells in Cell Therapy 3.1 Stem Cells Ability to Differentiate 3.1.1 Totipotent Stem Cells 3.1.2 Pluripotent Stem Cells 3.1.3 Multipotent
Cell Science 2017
It takes us immense pleasure to announce the conference that “Annual Congress on Cell Science, Stem Cell Research & Regenerative Medicine” which is going to be held during November 29-30, 2017 at Atlanta, USA. Cell Science 2017 conference will focus on the latest and exciting innovations in all areas of Cell Biologists and Stem Cell Researchers which offer a unique opportunity for investigators across the globe to meet, network, and perceive